Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
The first and only approved dual inhibitor of IL-17A and IL-17F1-6
February 2026
BIMZELX® Demonstrated Deep and Sustained Efficacy to 3 Years Across Multiple Disease Domains of PsA and the Full axSpA Spectrum…
Read more
22 May 2025
Transforming Rheumatology
In this series, Isabelle Amigues, rheumatologist and founder of UnabridgedMD, a direct rheumatology practice in Denver, Colorado, USA, discusses the importance of hope in patient care and the inspiration behind starting her own practice.
21 May 2025
Study Identifies Flare Risk in Rheumatoid Arthritis Remission
The UK BIO-FLARE study finds that half of rheumatoid arthritis patients relapse after stopping medication, with flare risk predicted by baseline clinical factors.
5
Mins
21 May 2025
Evolving Strategies in Lupus Care
Systemic lupus erythematosus (SLE) is a complex autoimmune disease that remains challenging to diagnose and treat. In this interview…
19 May 2025
Exercise Found to Reduce Risk of Developing Lupus
A large UK-based study has shown that individuals engaging in regular physical activity have a significantly lower risk of developing systemic lupus erythematosus, with benefits varying by age and sex.
17 May 2025
Knee Osteoarthritis Injections Less Likely with Timely Physical Therapy
Early initiation and consistent physical therapy may help reduce reliance on intra-articular injections for patients with newly diagnosed knee osteoarthritis, according to new real-world data.
15 May 2025
Ambulation Recovery Key in Metastatic Femur Fractures
Restoring walking ability after surgery for femoral metastasis is strongly tied to improved one-year survival, with early surgery and chemotherapy aiding recovery.
15 May 2025
Clinical Insights in Rheumatology
In this three-part series, Jonathan Sackier sits down with Richard Conway, rheumatologist, researcher, and educator. Together, they delve into cutting-edge insights on polymyalgia rheumatica, immune ageing, and the future of rheumatology care.
13 May 2025
Anti-Inflammatory Therapy Reduces Vascular Risk in Rheumatoid Arthritis
Anti-inflammatory treatment in RA patients significantly reduced biomarkers like IL-8 and E-selectin, with PET/CT imaging confirming corresponding decreases in arterial inflammation.
Loading posts...
« Previous
1
…
12
13
14
15
16
…
83
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View